Traws Pharma, Inc. (TRAW) Operating income 2015–2024
Traws Pharma, Inc. (TRAW) annual operating income history from SEC filings — each fiscal year as reported.
-$17.9MFY2024 · since FY2015: -$23.7M → -$17.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$17.9M | +87.4% |
| FY2023 | -$142.4M | -601.4% |
| FY2022 | -$20.3M | -3.4% |
| FY2021 | -$19.6M | -19.0% |
| FY2020 | -$16.5M | +34.0% |
| FY2019 | -$25.0M | -15.2% |
| FY2018 | -$21.7M | +6.8% |
| FY2017 | -$23.3M | +9.5% |
| FY2016 | -$25.7M | -8.6% |
| FY2015 | -$23.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating marginTRAW Operating cash flowTRAW Free cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →